HOTAIR, EgoA, and Nespas, which were found to be upregulated in NAFLD patients, were found to be expressed in 114 (63.34%), 97 (53.88%), and 91 (50.56%) samples, respectively. This evidence concerns the gene GNAS-AS1 and metabolic dysfunction-associated steatotic liver disease.